Ironwood reflux drug appears effective, safe in midstage trial

(Reuters) - Ironwood Pharmaceuticals Inc said on Thursday its potential blockbuster drug for gastroesophageal reflux disease (GERD) not controlled by current medicines significantly reduced heartburn severity and regurgitation frequency, meeting the main goals of a midstage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news